Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 8, 2010, Pages 3511-3516

  Swan, Laura E ^a   Tomasini, Livia ^a   Pirruccello, Michelle ^a   Lunardi, Joël ^b   De Camilli, Pietro ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Dent disease; Endocytosis; Lowe syndrome

Indexed keywords

ADAPTOR PROTEIN CONTAINING PLECKSTRIN PH DOMAIN PTB DOMAIN AND LEUCINE ZIPPER MOTIF 1; ENDOCYTIC PROTEIN SES1; ENDOCYTIC PROTEIN SES2; HISTIDINE; PHENYLALANINE; PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SUBPOPULATION; ENDOCYTOSIS; ENDOSOME; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ISOTHERMAL TITRATION CALORIMETRY; LOWE SYNDROME; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; STOP CODON;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CARRIER PROTEINS; CONSERVED SEQUENCE; ENDOCYTOSIS; ENDOSOMES; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; OCULOCEREBRORENAL SYNDROME; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN STRUCTURE, TERTIARY; VESICULAR TRANSPORT PROTEINS;

EID: 77649259149     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914658107     Document Type: Article

References (47)

1. Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651-657.
2. Vicinanza M, D'Angelo G, Di Campli A, De Matteis MA (2008) Function and dysfunction of the PI system in membrane trafficking. EMBO J 27:2457-2470.
3. Attree O, et al. (1992) The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358: 239-242.
4. Laporte J, et al. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13:175-182.
5. Bolino A, et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25:17-19.
6. Bielas SL, et al. (2009) Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat Genet 41: 1032-1036.
7. Jacoby M, et al. (2009) INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nat Genet 41:1027-1031.
8. McCrea HJ, De Camilli P (2009) Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology (Bethesda) 24:8-16.
9. Ooms LM, et al. (2009) The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J 419:29-49.
10. Zhang X, Jefferson AB, Auethavekiat V, Majerus PW (1995) The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc Natl Acad Sci USA 92:4853-4856.
11. Schurman SJ, Scheinman SJ (2009) Inherited cerebrorenal syndromes. Nat Rev Nephrol 5:529-538.
12. Delleman JW, Bleeker-Wagemakers EM, van Veelen AW (1977) Opacities of the lens indicating carrier status in the oculo-cerebro-renal (Lowe) syndrome. J Pediatr Ophthalmol 14:205-212.
13. Kleta R (2008) Fanconi or not Fanconi? Lowe syndrome revisited. Clin J Am Soc Nephrol 3:1244-1245.
14. Kenworthy L, Charnas L (1995) Evidence for a discrete behavioral phenotype in the oculocerebrorenal syndrome of Lowe. Am J Med Genet 59:283-290.
15. Dent CE, Friedman M (1964) Hypercalcuric rickets associated with renal tubular damage. Arch Dis Child 39:240-249.
16. Cho HY, et al. (2008) Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol 23:243-249.
17. Hoopes RR, Jr, et al. (2005) Dent disease with mutations in OCRL1. Am J Hum Genet 76:260-267.
18. Utsch B, et al. (2006) Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis 48 (6):942-956.
19. Shrimpton AE, et al. (2009) OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. Nephron Physiol 112:p27-p36.
20. Erdmann KS, et al. (2007) A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev Cell 13:377-390.
21. Mao Y, et al. (2009) A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism. EMBO J 28:1831-1842.
22. Choudhury R, Noakes CJ, McKenzie E, Kox C, Lowe M (2009) Differential clathrin binding and subcellular localization of OCRL1 splice isoforms. J Biol Chem 284: 9965-9973.
23. Choudhury R, et al. (2005) Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell 16:3467-3479.
24. Ungewickell A, Ward ME, Ungewickell E, Majerus PW (2004) The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin. Proc Natl Acad Sci USA 101:13501-13506.
25. Shin HW, et al. (2005) An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J Cell Biol 170:607-618.
26. Hyvola N, et al. (2006) Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases. EMBO J 25:3750-3761.
27. Fukuda M, Kanno E, Ishibashi K, Itoh T (2008) Large scale screening for novel Rab effectors reveals unexpected broad Rab binding specificity. Mol Cell Proteomics 7: 1031-1042.
28. Olivos-Glander IM, Jänne PA, Nussbaum RL (1995) The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex. Am J Hum Genet 57: 817-823.
29. McCrea HJ, et al. (2008) All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding. Biochem Biophys Res Commun 369: 493-499.
30. Addis M, Loi M, Lepiani C, Cau M, Melis MA (2004) OCRL mutation analysis in Italian patients with Lowe syndrome. Hum Mutat 23:524-525.
31. Lichter-Konecki U, Farber LW, Cronin JS, Suchy SF, Nussbaum RL (2006) The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function. Mol Genet Metab 89:121-128.
32. Kawano T, Indo Y, Nakazato H, Shimadzu M, Matsuda I (1998) Oculocerebrorenal syndrome of Lowe: Three mutations in the OCRL1 gene derived from three patients with different phenotypes. Am J Med Genet 77:348-355.
33. Lin T, et al. (1997) Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome. Am J Hum Genet 60:1384-1388.
34. Miaczynska M, et al. (2004) APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116:445-456.
35. Zoncu R, et al. (2009) A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell 136:1110-1121.
36. Bockenhauer D, et al. (2008) Renal phenotype in Lowe syndrome: A selective proximal tubular dysfunction. Clin J Am Soc Nephrol 3:1430-1436.
37. Yuksel A, Karaca E, Albayram MS (2009) Magnetic resonance imaging, magnetic resonance spectroscopy, and facial dysmorphism in a case of Lowe syndrome with novel OCRL1 gene mutation. J Child Neurol 24:93-96.
38. Monnier N, Satre V, Lerouge E, Berthoin F, Lunardi J (2000) OCRL1 mutation analysis in French Lowe syndrome patients: Implications for molecular diagnosis strategy and genetic counseling. Hum Mutat 16:157-165.
39. Giot L, et al. (2003) A protein interaction map of Drosophila melanogaster. Science 302:1727-1736.
40. Shaner NC, et al. (2008) Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat Methods 5:545-551.
41. Simonsen A, et al. (1998) EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 394:494-498.
42. Fritzius T, et al. (2006) A WD-FYVE protein binds to the kinases Akt and PKCzeta/ lambda. Biochem J 399:9-20.
43. Hayakawa A, et al. (2006) The WD40 and FYVE domain containing protein 2 defines a class of early endosomes necessary for endocytosis. Proc Natl Acad Sci USA 103: 11928-11933.
44. Frith MC, Hansen U, Spouge JL, Weng Z (2004) Finding functional sequence elements by multiple local alignment. Nucleic Acids Res 32:189-200.
45. Marshall AJ, et al. (2000) A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase. J Exp Med 191:1319-1332.
46. Dowler S, Currie RA, Downes CP, Alessi DR (1999) DAPP1: A dual adaptor for phosphotyrosine and 3-phosphoinositides. Biochem J 342:7-12.
47. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics International 11:36-42.